Who We Fund
Since 1949, LLS has provided more than $1.7 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Bruno Paiva
smoldering myeloma
Keisuke Ito
blood cancer stem cells and MDS metabolism
Robert Kridel
follicular lymphoma
Jason Butler
aging and leukemia
Thomas Kipps
Hairy Cell Leukemia
Jian Xu
leukemia and MPN biology
Larry Kwak
Mantle cell lymphoma, immunotherapy
Tanya Siddiqi
clinical trial access
Jaehyuk Choi
T-cell lymphoma
Brian Walker
smoldering myeloma, MGUS
Shannon Maude
Immunotherapy for ALL
Daniel Lucas
bone marrow and leukemia biology
Johann-Christoph Jann
AML/MDS
Frederick Locke
lymphoma and immunotherapy
Madhav Dhodapkar
multiple myeloma immunotherapy
Areej El-Jawahri
transplant survivorship
Julia Paczkowska
immunobiology of Hodgkin's disease
Carl June
CAR T immunotherapy
Lori Muffly
Equity in Access
Mark Hamilton
DLBCL and CAR-T
Amin Sobh
Myeloma biology
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Jeffrey Magee
pediatric AML
Alex Kentsis
pediatric leukemias
Luca Busino
DLBCL
Enterome
vaccine, FL, MZL
Zhijian Qian
blood cancer stem cells
Craig Jordan
AML
Inhye Ahn
CLL
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Katherine Borden
AML
William Matsui
Myeloma
Huda Salman
CMML
Christian Steidl
B-cell lymphomas
Matthew Frank
Lymphoma CART therapy
Britta Will
Leukemia and pre-leukemia
Meng Li
Equity in Access
Nizar Bahlis
Myeloma immunotherapy
Kerry Rogers
CLL
Eric Pietras
AML
Stacie Dusetzina
Equity in Access
Carisma Therapeutics
immunotherapy, CAR-macrophage
Jennifer Woyach
CLL trials
Dan Landau
cancer evolution biology
Kirk Schultz
pediatric transplantation
Jaroslaw Maciejewski
bone marrow failure
Robert Bradley
MDS
Jing Yang
Myeloma
Jianhua Yu
myeloma immunotherapy
Sergei Doulatov
Leukemias
Amit Verma
AML/MDS
Roland Walter
Antibody-based AML therapies
Michael Savona
MDS and leukemia
Michael Keller
COVID-19, immunotherapy
Robert Soiffer
transplantation
Susan Schwab
cancer immunology
Tak Mak
Immunotherapy
Steven Horwitz
T-cell lymphomas
Michael Green
lymphoma biology
Daniel Starczynowski
MDS and AML
Yan Liu
MDS
Christopher Booth
BPDCN
Arash Alizadeh
blood cancer biology and diagnosis
Zachary Hunter
Waldenström macroglobulinemia (WM)
Rajni Kumari
AML
Jonathon Cohen
lymphoma clinical trial access in Georgia
Stephen Nimer
myeloid cancer biology
Constellation Pharmaceuticals
myeloproliferative neoplasms
David Ritchie
Hairy Cell Leukemia
Daisuke Nakada
preleukemia, leukemia
Lindsey Montefiori
pediatric leukemia
Ryvu Therapeutics
AML, MDS
Kymera Therapeutics
protein degraders, DLBCL, TCL, LGLL
Ravindra Majeti
preleukemia, AML
Maria "Ken" Figueroa
aging and leukemia
David Fruman
novel combinations
Courtney Jones
AML metabolism
Helen Parsons
Equity in Access
Kasey Leger
pediatric blood cancers
Ricky Johnstone
lymphoma and myeloma
Cailin Collins
Leukemia and pre-leukemia
Kathleen Sakamoto
pediatric AML
Adam de Smith
pediatric ALL and Down Syndrome
Jonas Jutzi
myeloproliferative neoplasms
Qingyu Luo
BPDCN
Catherine Smith
leukemia
Ronald Levy
immunotherapies, COVID-19
Timothy Ley
AML, precision medicine
Yusuke Isshiki
DLBCL and GCB Lymphomas
Logan Spector
childhood leukemia epidimiology
Lev Kats
myeloma and epigenetics
Eirini Papapetrou
blood cancer stem cells
Robert Signer
cancer stem cell biology
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Pietro Genovese
transplant and AML
Michael Rout
follicular lymphoma, CAR T
Lawrence Boise
CART and myeloma
Armin Rashidi
gut bacteria and transplant success
Grant Challen
preleukemia, leukemia
Jennifer Trowbridge
aging and leukemia
Charles Mullighan
pediatric ALL
Sarah Tasian
pediatric leukemias
Timothy Graubert
AML and MDS biology
Tomasz Skorski
myeloproliferative neoplasms, AML
Nicolas Nassar
pediatric leukemia
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Alexey Danilov
lymphoma
Marina Konopleva
MDS/AML metabolism
F. Lennie Wong
Equity in Access
Alison Moskowitz
lymphoma therapeutics
Rgenta Therapeutics
RNA-targeting, blood cancer
Daniel Thomas
Myelofibrosis
Noemí Puig Morón
Myeloma
Courtney DiNardo
clinical trials, AML
Mark Dawson
B-ALL and CAR-T resistance
Selina Chen-Kiang
Mantle cell lymphoma
Coleman Lindsley
AML/MDS
Mitchell Geer
leukemia biology
Sami Malek
blood cancer biology
Helen Heslop
Immunotherapy
Paolo Strati
Non-Hodgkin Lymphoma
Joachim Yahalom
Lymphoma
Lucy Godley
preleukemia
ImCheck Therapeutics
immunotherapy, AML
Carl Allen
pediatric blood cancers
Martin Dreyling
Mantle Cell Lymphoma
Jonathan Licht
DNA biology, myeloma
Matteo Bellone
Smoldering multiple myeloma
John Pimanda
AML, MDS
Michael Wang
Mantle Cell Lymphoma
Christiane Querfeld
T-cell lymphoma
Alec Zhang
myeloma, immunotherapy
Venkata Lokesh Battula
immunotherapy and AML
Liran Shlush
pre-leukemia
Kevin Shannon
pediatric AML
Clayton Smith
clinical trial access
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Justine Kahn
pediatric leukemia and lymphoma
Trent Hall
MDS
Robert Orlowski
(Smoldering) Multiple Myeloma
Adi Nagler
Bronchiolitis obliterans after transplant
Caroline Arber
myeloma CAR-T
Mendel Goldfinger
MDS/AML trials for the elderly
BioInvent International
immunotherapy, indolent NHL, CTCL
Kehan Ren
MDS
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Alexandra Stevens
childhood AML
Oreofe Odejide
Equity in Access
George Vassiliou
pre-leukemia
Faron Pharmaceuticals
immunotherapy, MDS
Hong Wen
AML
John Crispino
MPNs, myelofibrosis
Adam Olszewski
Follicular and marginal zone lymphoma
Dane Vassiliadis
blood cancer biology
Kimberly Stegmaier
childhood blood cancers
Kirsten Williams
leukemia, immunotherapy
Caron Jacobson
lymphoma and immunotherapy
Nirav Shah
CAR-T for lymphoma
Kura Oncology
MLL leukemia, AML
Shannon McKinney-Freeman
transplant biology
Sahand Hormoz
MPN
Sylvain Simon
Immunotherapy, CAR-T safety
Abintus Bio
immunotherapy, in vivo CAR
Thomas LeBlanc
palliative care
Sam Butterworth
CMML
Christopher Flowers
clinical trial access
Simona Colla
Myeloma biology
Thorsten Zenz
Hairy cell leukemia
Sisi Chen
leukemia
Richard Lock
T-ALL
Neha Mehta-Shah
T-cell lymphoma
Eugenio Morelli
Myeloma
Alex Herrera
lymphoma and immunotherapy
Shan Lin
preleukemia, leukemia
Stephen Gottschalk
pediatric leukemia and CAR-T
Matthew Schwede
machine learning and AML
Ryan Wilcox
T-cell lymphoma
Andrew Lane
BPDCN
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Hao Jiang
leukemia biology
Peng Ji
myeloproliferative neoplasms
Suzanne Lentzsch
Myeloma
Thomas Koehnke
leukemia
Megan McNerney
AML/MDS
Rizwan Romee
Immunotherapy
Ari Melnick
epigenetics and lymphoma
Jayna Mistry
aging and leukemias
Steven Treon
Lymphomas and Waldenstrom's
Xu Ji
Equity in Access
Alfred Garfall
myeloma immunotherapy
Wendy Stock
T-cell ALL
Jessica Stewart
Epstein-barr virus and lymphomas
Wendy Béguelin
follicular lymphoma
Mala Shanmugam
myeloma
Ann-Kathrin Eisfeld
Racial diversity in AML
Qing Yi
Novel CAR-T
Daniel Herranz
T-ALL
Gareth Morgan
smoldering myeloma, MGUS
Jenny Wang
AML
Ryotaro Nakamura
ALL, CAR T
Eric Padron
CMML
Yiman Liu
Epigenetics and leukemia
Dan Vogl
myeloma, microenvironment
Yubin Zhou
peripheral T cell lymphoma
Christopher Reilly
leukemia
Rong Lu
preleukemia, leukemia
Aditi Shastri
AML, MDS
Baochun Zhang
immunotherapy
Jolanta Grembecka
leukemia therapeutics
Alieen Rowan
Adult T cell leukemia/lymphoma
Piers Patten
COVID-19
Ruben Carrasco
Myeloma
Margaret Shipp
lymphoma biology
Sean Post
diffuse large B-cell lymphoma
Caner Saygin
T-ALL
Ravi Bhatia
transplantation
Peter Klein
MDS
Tycel Phillips
Mantle Cell Lymphoma
Riccardo Dalla-Favera
lymphoma (DLBCL)
Affimed
immunotherapy, HL, PTCL
Suman Paul
T cell cancers and immunotherapy
Randall Davis
CLL
Saar Gill
AML immunotherapy
Omar Abdel-Wahab
Hairy cell leukemia
Markus Muschen
leukemia and lymphoma biology
Amer Zeidan
MDS and AML
Therese Vu
T-All and MLL
Lakshmi Nayak
brain tumors in lymphoma
Gaurav Goyal
Erdheim-Chester Disease
Roberta Zappasodi
lymphoma, immunotherapy
Nitin Jain
CLL
Brian Dalton
DNA mutations and myeloid cancers
Dren Bio
immunotherapy, LGLL
Liling Wan
AML
Catriona Jamieson
cancer stem cell biology
Frederike Kramer
MPNs
Juliette Bouyssou
leukemias and gender
Loren Walensky
pediatric leukemia
Yibin Yang
Lymphoma
Julia Maxson
AML
Dimericon Therapeutics
dimericons, blood cancer
Jalpa Doshi
Equity in Access
Michael Kharas
leukemia
Daniel Pollyea
AML
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Forty Seven
immunotherapy, AML
Jeremy Baeten
AML
Marc Seifert
Hairy cell leukemia
Elliot Stieglitz
CMML
Soheil Meshinchi
pediatric AML
Srividya Swaminathan
pediatric, immunotherapy
Reshmi Parameswaran
immunotherapy for hairy cell leukemia
Samuel Taylor
leukemia biology
Enrico Tiacci
Hairy cell leukemia
Takeshi Sugio
T-cell lymphoma
Catherine Bollard
pediatric blood cancers and immunotherapy
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Grzegorz Nowakowski
Clinical trial access
Jennifer Lewis
URM Student
Taishi Yonezawa
AML
Stephen Oh
myeloproliferative neoplasms
Jianguo Tao
Mantle Cell Lymphoma
Anna Lee
AML
John Leonard
lymphoma research
Tyler Parsons
MPN and AML
Maximilian Stahl
AML immunotherapy
G. Greg Wang
DNA biology
Christopher Porter
Leukemia, lymphoma
Nathan Ungerleider
lymphoma biology
Marco Ruella
Immunotherapy for T-cell lymphoma
Sigurður Kristinsson
Smoldering myeloma
Christine Zhang
AML
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Siddhartha Jaiswal
preleukemia
Gianpietro Dotti
CAR T and AML
Koichi Takahashi
AML/MDS
Sameer Parikh
COVID-19
Christian Marinaccio
MLL leukemias
Shirong Li
myeloma
Sattva Neelapu
DLBCL, CAR T
Jun Qi
Myeloma